Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F
about
A Genetic-Pathophysiological Framework for CraniosynostosisFibroblast growth factor signaling in skeletal development and diseaseMutation in osteoactivin decreases bone formation in vivo and osteoblast differentiation in vitro.Common and specific effects of TIE2 mutations causing venous malformationsC1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2.A missense mutation in Fgfr1 causes ear and skull defects in hush puppy mice.Loss-of-function fibroblast growth factor receptor-2 mutations in melanomaMannose phosphate isomerase regulates fibroblast growth factor receptor family signaling and glioma radiosensitivity.Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis.A novel role for inducible Fut2 in angiogenesisFGFR4 and its novel splice form in myogenic cells: Interplay of glycosylation and tyrosine phosphorylation.Bent bone dysplasia-FGFR2 type, a distinct skeletal disorder, has deficient canonical FGF signaling.Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.Quantification of shape and cell polarity reveals a novel mechanism underlying malformations resulting from related FGF mutations during facial morphogenesis.GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironmentFGF/FGFR signaling in bone formation: progress and perspectives.The Fgfr2 W290R mouse model of Crouzon syndrome.Revisiting Crouzon syndrome: reviewing the background and management of a multifaceted disease.FGF2 promotes Msx2 stimulated PC-1 expression via Frs2/MAPK signaling.FGFR2 ligand binding and activationA novel FGFR2 mutation in tyrosine kinase II domain, L617F, in Crouzon syndrome.JNK/ERK/FAK mediate promigratory actions of basic fibroblast growth factor in astrocytes via CCL2 and COX2.Activated FGFR1 mutants and fusions bind PLCG1Activated FGFR2 mutants bind PLCG1Activated FGFR3 mutants bind PLCG1Activated FGFR4 mutants bind PLCG1Activated FGFR1 binds PLCG1Activated FGFR2 binds PLCG1Activated FGFR3 binds PLCG1Activated FGFR4 binds PLCG1Ectrodactyly and Lethal Pulmonary Acinar Dysplasia Associated with Homozygous FGFR2 Mutations Identified by Exome Sequencing.Atypical Crouzon syndrome with a novel Cys62Arg mutation in FGFR2 presenting with sagittal synostosis.Mouse FLRT2 interacts with the extracellular and intracellular regions of FGFR2.
P2860
Q26784240-CF928052-B455-44C5-963F-4A4A1A80F77AQ26798215-8F37CE5C-0EB0-4591-B079-5236BD28A6C4Q30417516-4F7A729B-D2F1-4D5C-B705-D6CB93F19888Q30670028-8F82CE94-446B-4EDD-84F1-F47760C8AB32Q33688535-98C71890-6B8D-42C6-9891-8D6BE96A9495Q34177207-959113F7-6646-4792-B9D8-73B6B6AA1F6CQ34520671-3B1D025F-B180-4A1E-A39B-F117D818905BQ35331391-F77E6073-CDDB-4078-B539-D369101F1A8EQ35635057-2A4560D7-6D03-4C4E-A9F4-24CEF956D4BAQ35636363-26EAEBB9-2F04-4681-B5E9-4D4E3326594EQ35746523-A1A6D821-72BD-4F62-B5D6-C6F0880BD20FQ35843212-86813D50-B635-4FFF-855D-29997ED9374DQ36741513-34DBC70A-C49D-4A41-A39E-A518EA33D9AEQ37346972-515F3274-0062-4D5E-A711-CCF0A18A3B85Q37519157-70FD88DF-8AFB-411F-A191-0DCF3A1F8254Q37980181-C874CBAC-865B-47C0-B658-5A682C92C8BBQ38032781-C95D4392-81A0-47C8-BF8D-C8771CCDC339Q38253195-9A4AA70E-FDD3-4158-A0B0-448F08F93CB0Q38430529-14ADB7E0-1516-4BD7-A229-800A9430E926Q45317974-D2E0AD3E-8880-4994-97E0-8FF85CB4EC0FQ47862123-570077AC-D220-446E-80AA-3662103E699FQ48762699-7E0262C1-AD86-439A-B040-F3F5E5E2EE83Q50288695-FC5A992D-9D86-4B10-9D2B-52715D242803Q50288729-CAB92823-417B-4570-95F3-7EB591102527Q50288752-B342CD0C-C2CA-4418-971E-272951CA5E71Q50288786-7346215D-0A12-4288-8A70-E36616DCB368Q50297535-88143CD6-111D-4C20-90AD-ACB9DCB99193Q50297587-7D3D192C-0CA9-4FA5-8410-DBEF9BCE65AAQ50297621-E53E0B75-163F-4495-BD32-EC93596B7400Q50297656-5397DE28-9494-435B-9F49-2AA0458AB2DDQ51692598-BD106AC7-99EB-476F-92F3-2BC9439D7BADQ51841459-89981490-599D-4CA4-BCC3-5B91D7BEA366Q51860675-7983D466-B3FB-4638-8F0B-7ECD9FFE19CD
P2860
Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@ast
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en-gb
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@nl
type
label
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@ast
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en-gb
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@nl
prefLabel
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@ast
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en-gb
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@nl
P2093
P2860
P921
P356
P1476
Intracellular retention, degra ...... syndrome-associated FGFR2C278F
@en
P2093
Marianne L Seto
Mark Hudson
Michael L Cunningham
P2860
P304
27292-27305
P356
10.1074/JBC.M600448200
P407
P577
2006-07-14T00:00:00Z